Etzer Darout Score: 35
Analyst at
Barclays
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+21.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
64%
49 W / 27 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
62%
41 W / 25 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
12%
8 W / 58 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
3%
2 W / 64 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
60%
34 W / 23 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
65%
46 W / 25 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
60%
3 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 01, 2026 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$180.00
Est. +22%
|
$147.75 | $151.27 |
Pending
|
$141.86
-4.0%
|
| Aug 18, 2026 |
Enliven Therapeutics Inc
ELVN
|
BUY |
$78.00
Est. +31%
|
$59.54 | $62.00 |
Pending
|
$44.75
-24.8%
|
| Aug 07, 2026 |
Relay Therapeutics Inc
RLAY
|
BUY |
$30.00
Est. +52%
|
$19.75 | $20.98 |
Pending
|
$17.47
-11.5%
|
| Jul 28, 2026 |
Forte Biosciences Inc
FBRX
|
BUY |
$77.00
Est. +1%
|
$76.50 | $77.20 |
Bullseye Hit (±1%)
|
$76.99
+0.6%
|
| Jul 14, 2026 |
Exelixis Inc
EXEL
|
SELL |
$49.00
Est. +13%
|
$56.04 | $49.97 (Low) |
Precision Hit (±3%)
|
$58.16
-3.8%
|
| May 06, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$234.00
Est. +10%
|
$212.26 | $266.38 |
Target Met
|
$237.95
+12.1%
|
| Apr 27, 2026 |
Oruka Therapeutics, Inc.
ORKA
|
BUY |
$160.00
Est. +99%
|
$80.35 | $112.95 |
Pending
|
$84.46
+5.1%
|
| Apr 20, 2026 |
Janux Therapeutics Inc
JANX
|
SELL |
$14.00
Est. +12%
|
$15.82 | $12.99 (Low) |
Target Met
|
$16.30
-3.0%
|
| Apr 20, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$225.00
Est. +11%
|
$203.42 | $266.38 |
Target Met
|
$237.95
+17.0%
|
| Mar 09, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$224.00
Est. +21%
|
$185.40 | $266.38 |
Target Met
|
$237.95
+28.3%
|
| Mar 03, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$53.00
Est. +20%
|
$44.31 | $61.75 |
Target Met
|
$48.63
+9.7%
|
| Feb 26, 2026 |
C4 Therapeutics Inc
CCCC
|
BUY |
$7.00
Est. +149%
|
$2.81 | $5.17 |
Pending
|
$2.98
+6.0%
|
| Feb 04, 2026 |
Exelixis Inc
EXEL
|
BUY |
$44.00
Est. +3%
|
$42.59 | $59.72 |
Target Met
|
$58.16
+36.6%
|
| Feb 04, 2026 |
Vir Biotechnology Inc
VIR
|
BUY |
$24.00
Est. +213%
|
$7.68 | $11.94 |
Pending
|
$10.66
+38.8%
|
| Jan 20, 2026 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$8.00
Est. +48%
|
$5.39 | $8.20 |
Precision Hit (±3%)
|
$2.70
-49.9%
|
| Dec 17, 2025 |
AnaptysBio Inc
ANAB
|
BUY |
$55.00
Est. +22%
|
$45.03 | $72.27 |
Target Met
|
$51.00
+13.3%
|
| Dec 17, 2025 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$52.00
Est. +17%
|
$44.32 | $61.75 |
Target Met
|
$48.63
+9.7%
|
| Dec 09, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$56.00
Est. +39%
|
$40.23 | $53.18 |
Pending
|
$52.95
+31.6%
|
| Nov 25, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$36.00
Est. +28%
|
$28.04 | $53.18 |
Target Met
|
$52.95
+88.8%
|
| Nov 24, 2025 |
Kura Oncology Inc
KURA
|
BUY |
$28.00
Est. +151%
|
$11.17 | $13.90 |
Pending
|
$10.76
-3.7%
|
| Nov 17, 2025 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$152.00
Est. +41%
|
$108.00 | $123.99 |
Pending
|
$123.96
+14.8%
|
| Nov 05, 2025 |
Exelixis Inc
EXEL
|
BUY |
$41.00
Est. +8%
|
$37.90 | $59.72 |
Target Met
|
$58.16
+53.5%
|
| Oct 29, 2025 |
Xencor Inc
XNCR
|
BUY |
$23.00
Est. +61%
|
$14.25 | $30.60 |
Target Met
|
$23.80
+67.0%
|
| Oct 22, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$14.00
Est. +86%
|
$7.53 | $53.18 |
Target Met
|
$52.95
+603.2%
|
| Oct 21, 2025 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$6.00
Est. +60%
|
$3.74 | $8.20 |
Target Met
|
$2.70
-27.8%
|
| Oct 13, 2025 |
Abivax - ADR
ABVX
|
BUY |
$142.00
Est. +51%
|
$93.77 | $148.83 |
Target Met
|
$91.06
-2.9%
|
| Oct 13, 2025 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$125.00
Est. +42%
|
$87.82 | $124.42 |
Bullseye Hit (±1%)
|
$85.24
-2.9%
|
| Sep 24, 2025 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$44.00
Est. +32%
|
$33.39 | $61.75 |
Target Met
|
$48.63
+45.6%
|
| Sep 22, 2025 |
C4 Therapeutics Inc
CCCC
|
BUY |
$10.00
Est. +216%
|
$3.16 | $5.17 |
Miss
|
$2.98
-5.7%
|
| Sep 16, 2025 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$3.50
Est. +79%
|
$1.96 | $8.20 |
Target Met
|
$2.70
+37.8%
|
Protagonist Therapeutics Inc
PTGX
Sep 01, 2026
Signal & Target
BUY
$180.00
Start Price
$147.75
Best Price (1Y)
$151.27
Current Price
$141.86
Return
-4.0%
Enliven Therapeutics Inc
ELVN
Aug 18, 2026
Signal & Target
BUY
$78.00
Start Price
$59.54
Best Price (1Y)
$62.00
Current Price
$44.75
Return
-24.8%
Relay Therapeutics Inc
RLAY
Aug 07, 2026
Signal & Target
BUY
$30.00
Start Price
$19.75
Best Price (1Y)
$20.98
Current Price
$17.47
Return
-11.5%
Forte Biosciences Inc
FBRX
Jul 28, 2026
Signal & Target
BUY
$77.00
Start Price
$76.50
Best Price (1Y)
$77.20
Current Price
$76.99
Return
+0.6%
Exelixis Inc
EXEL
Jul 14, 2026
Signal & Target
SELL
$49.00
Start Price
$56.04
Best Price (1Y)
$49.97
Current Price
$58.16
Return
-3.8%
Jazz Pharmaceuticals plc
JAZZ
May 06, 2026
Signal & Target
BUY
$234.00
Start Price
$212.26
Best Price (1Y)
$266.38
Current Price
$237.95
Return
+12.1%
Oruka Therapeutics, Inc.
ORKA
Apr 27, 2026
Signal & Target
BUY
$160.00
Start Price
$80.35
Best Price (1Y)
$112.95
Current Price
$84.46
Return
+5.1%
Janux Therapeutics Inc
JANX
Apr 20, 2026
Signal & Target
SELL
$14.00
Start Price
$15.82
Best Price (1Y)
$12.99
Current Price
$16.30
Return
-3.0%
Jazz Pharmaceuticals plc
JAZZ
Apr 20, 2026
Signal & Target
BUY
$225.00
Start Price
$203.42
Best Price (1Y)
$266.38
Current Price
$237.95
Return
+17.0%
Jazz Pharmaceuticals plc
JAZZ
Mar 09, 2026
Signal & Target
BUY
$224.00
Start Price
$185.40
Best Price (1Y)
$266.38
Current Price
$237.95
Return
+28.3%
Scholar Rock Holding Corp
SRRK
Mar 03, 2026
Signal & Target
BUY
$53.00
Start Price
$44.31
Best Price (1Y)
$61.75
Current Price
$48.63
Return
+9.7%
C4 Therapeutics Inc
CCCC
Feb 26, 2026
Signal & Target
BUY
$7.00
Start Price
$2.81
Best Price (1Y)
$5.17
Current Price
$2.98
Return
+6.0%
Exelixis Inc
EXEL
Feb 04, 2026
Signal & Target
BUY
$44.00
Start Price
$42.59
Best Price (1Y)
$59.72
Current Price
$58.16
Return
+36.6%
Vir Biotechnology Inc
VIR
Feb 04, 2026
Signal & Target
BUY
$24.00
Start Price
$7.68
Best Price (1Y)
$11.94
Current Price
$10.66
Return
+38.8%
CytomX Therapeutics Inc
CTMX
Jan 20, 2026
Signal & Target
BUY
$8.00
Start Price
$5.39
Best Price (1Y)
$8.20
Current Price
$2.70
Return
-49.9%
AnaptysBio Inc
ANAB
Dec 17, 2025
Signal & Target
BUY
$55.00
Start Price
$45.03
Best Price (1Y)
$72.27
Current Price
$51.00
Return
+13.3%
Scholar Rock Holding Corp
SRRK
Dec 17, 2025
Signal & Target
BUY
$52.00
Start Price
$44.32
Best Price (1Y)
$61.75
Current Price
$48.63
Return
+9.7%
Terns Pharmaceuticals Inc
TERN
Dec 09, 2025
Signal & Target
BUY
$56.00
Start Price
$40.23
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+31.6%
Terns Pharmaceuticals Inc
TERN
Nov 25, 2025
Signal & Target
BUY
$36.00
Start Price
$28.04
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+88.8%
Kura Oncology Inc
KURA
Nov 24, 2025
Signal & Target
BUY
$28.00
Start Price
$11.17
Best Price (1Y)
$13.90
Current Price
$10.76
Return
-3.7%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Nov 17, 2025
Signal & Target
BUY
$152.00
Start Price
$108.00
Best Price (1Y)
$123.99
Current Price
$123.96
Return
+14.8%
Exelixis Inc
EXEL
Nov 05, 2025
Signal & Target
BUY
$41.00
Start Price
$37.90
Best Price (1Y)
$59.72
Current Price
$58.16
Return
+53.5%
Xencor Inc
XNCR
Oct 29, 2025
Signal & Target
BUY
$23.00
Start Price
$14.25
Best Price (1Y)
$30.60
Current Price
$23.80
Return
+67.0%
Terns Pharmaceuticals Inc
TERN
Oct 22, 2025
Signal & Target
BUY
$14.00
Start Price
$7.53
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+603.2%
CytomX Therapeutics Inc
CTMX
Oct 21, 2025
Signal & Target
BUY
$6.00
Start Price
$3.74
Best Price (1Y)
$8.20
Current Price
$2.70
Return
-27.8%
Abivax - ADR
ABVX
Oct 13, 2025
Signal & Target
BUY
$142.00
Start Price
$93.77
Best Price (1Y)
$148.83
Current Price
$91.06
Return
-2.9%
Monopar Therapeutics Inc
MNPR
Oct 13, 2025
Signal & Target
BUY
$125.00
Start Price
$87.82
Best Price (1Y)
$124.42
Current Price
$85.24
Return
-2.9%
Scholar Rock Holding Corp
SRRK
Sep 24, 2025
Signal & Target
BUY
$44.00
Start Price
$33.39
Best Price (1Y)
$61.75
Current Price
$48.63
Return
+45.6%
C4 Therapeutics Inc
CCCC
Sep 22, 2025
Signal & Target
BUY
$10.00
Start Price
$3.16
Best Price (1Y)
$5.17
Current Price
$2.98
Return
-5.7%
CytomX Therapeutics Inc
CTMX
Sep 16, 2025
Signal & Target
BUY
$3.50
Start Price
$1.96
Best Price (1Y)
$8.20
Current Price
$2.70
Return
+37.8%